Wilgen Congratulates The Winners Of The Biotech Venture Lounge 2014

Luxembourg, 13 May 2014 - Following the Biotech Venture Lounge organised on 30 April 2014 in Luxembourg and sponsored by Wildgen and the LPEA (Luxembourg Privare Equity and Venture Capital Association), we are pleased to announce that SeaLife Pharma, an innovative Austrian drug manufacturer, has been awarded "Best start-up from the Biotech sector" and received a comprehensive package from the Wildgen law firm.

Emmanuelle Ragot, Head of IP/TMT at Wildgen and speaker at the event with Laurent Mahaux, Tax Director, comments: "This edition was once again the perfect occasion for the selected start-ups to present their business and connect with financially strong investors. I congratulate the three winners: SeaLife Pharma GmbH, ALRISE Biosystems GmbH and Amakem Therapeutics which convinced the jury with their innovation and ideas and also compliment the organisers on the event which actively contributes to the promotion of Luxembourg as a European...